SOLICITATION NOTICE
68 -- Contract for Oral Rabies Vaccine - ONRABŪ Ultralite baits
- Notice Date
- 7/19/2017
- Notice Type
- Cancellation
- NAICS
- 325414
— Biological Product (except Diagnostic) Manufacturing
- Contracting Office
- Department of Agriculture, Animal and Plant Health Inspection Service, Administrative Services Division/Contracting, 100 North 6TH Street, Butler Square 5TH Floor, Minneapolis, Minnesota, 55403
- ZIP Code
- 55403
- Solicitation Number
- PR-17-866160
- Archive Date
- 8/18/2017
- Point of Contact
- Carol R. Dingess, Phone: 970-494-7360
- E-Mail Address
-
carol.dingess@aphis.usda.gov
(carol.dingess@aphis.usda.gov)
- Small Business Set-Aside
- N/A
- Description
- The United States Department of Agriculture (USDA)/Animal Plant Health Inspection Service (APHIS)/Wildlife Services (WS), National Rabies Management Program in Concord, NH, intends to award a sole-source contract to Artemis Technologies, LLC, for the supply of the oral rabies vaccine ONRAB® Ultralite baits. WS proposes to purchase up to 2,502,900 units of the vaccine during 2017. This procurement is being conducted in accordance with FAR 6.302-1 and 41 U.S.C. 3304(a)(1). USDA, APHIS, WS and state and federal collaborators conducted field trials during 2011-2014 to evaluate the safety and efficacy of a human adenovirus type 5-rabies glycoprotein recombinant (AdRG1.3) ONRAB® rabies vaccine in raccoons and striped skunks. To date, Raboral V-RG® (a vaccinia-rabies glycoprotein recombinant oral rabies vaccine), the only oral rabies vaccine licensed for use in the United States to control rabies in raccoons and coyotes, has been the only oral rabies vaccine used operationally in rabies control campaigns. This vaccine has allowed WS and cooperators to prevent raccoon rabies from spreading appreciably, but achieving elimination of raccoon rabies is expected to require higher levels of rabies antibody seroconversion in raccoon populations targeted for oral vaccination at currently used bait densities. In addition, there is a need to orally vaccinate skunks as raccoon rabies often spills over into the skunk population, a potential source of re-infection in raccoons. ONRAB® has been identified as a candidate for testing, in part, because this oral vaccine demonstrated higher levels of rabies antibody seroconversion in raccoons than the oral vaccine currently in use in the United States in two cross-border comparison studies. In addition, it has produced favorable control in raccoons and, in some cases, skunks in Canada. Although the recombinant ONRAB® vaccine has been used extensively in southern Ontario since 2006 and Quebec since 2007 with good reported success, these field trials represented the first release of this vaccine into the field in the United States. Continued field trial expansion in 2013 was considered warranted based on the favorable safety and vaccine-induced antibody results of the first field trial with ONRAB® in an Ultralite bait conducted in 2011. In 2013, WS expanded field trials to include an area in Northern New York (St. Lawrence County) to scientifically replicate field trials that were conducted in VT, NH and NY in 2012-2014. In 2015, WS concluded field trials in Northern New York (St. Lawrence County). WS also began to evaluate the ONRAB® vaccine-bait at different baiting densities in WV, VT, and NH during 2015, which will extend until 2017. In order to fully scientifically test the immunogenicity of this vaccine under field conditions, it will require up to three field seasons at each location. This is why WS intends to purchase the ONRAB baits under this single source contract to Artemis Technologies through 2017 in order to fully complete field trials. This is not a request for competitive proposals. No solicitation documents are available and telephone requests will not be honored. However, if a firm believes it can meet the requirements it must furnish information about its product to the Contract Specialist listed on this notice by 4 p.m. Mountain Time on the closing date of this notice. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to comply with the above requirement. The NAICS code for this acquisition is 325414 - Biological Product (except Diagnostic) Manufacturing, and the small business size standard is 1,250 Employees. Responses received after the response date or without the required information will not be considered. Capability statements may be sent via email: Carol.Dingess@aphis.usda.gov, fax @ 970-472-1897, or mailed to: Carol Dingess, Contract Specialist, USDA-APHIS-MRPBS, AAMD Procurement Branch, 2150 Centre Avenue Building B MS (2E6) Fort Collins, CO 80526.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/USDA/APHIS/Contracting/PR-17-866160/listing.html)
- Place of Performance
- Address: USDA,APHIS,Wildlife Services, National Rabies Management Program, 59 Chenell Dr., Ste. 2, Concord, New Hampshire, 03301, United States
- Zip Code: 03301
- Zip Code: 03301
- Record
- SN04586353-W 20170721/170719235321-ee3e7517377bad7b1696eb94aedc5da4 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |